Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma - Results of 152 resected cases

Hepato-Gastroenterology

Volumn 54, Issue 79, 2007, Pages 2084-2087

  Shirabe, Ken ^a   Wakiyama, Shigeki ^a   Gion, Tomonobu ^a   Motomura, Kenta ^a   Koyanagi, Toshimasa ^a   Sakamoto, Shigeru ^a   Nagaie, Takashi ^a  

^a ASO IIZUKA HOSPITAL   (Japan)

Author keywords

Hepatic resection; Hepatocellular carcinoma; Recurrence pattern

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; HEPATITIS C ANTIBODY; INDOCYANINE GREEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; TUMOR VOLUME;

AGED; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK ASSESSMENT; RISK FACTORS;

EID: 37749013659     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K: A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 2002; S153-1538.
2. Kaido T, Arii S, Oe H, Mori A, Imamura M: Predictive factors affecting early recurrence after hepatectomy for hepatocellular carcinoma in 5-year survivors. Hepatogastroenterology 2005; 52(65):1484-1487.
3. Fukuda S, Itamoto T, Nakahara H, Kohashi T, Ohdan H, Hino H, Ochi M, Tashiro H, Asahara T: Clinico pathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 2005; 52(64):1163-1167.
4. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K: Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991; 14(5):802-805.
5. Tarao K, Rino Y, Ohkawa S, Tamai S, Miyakawa K, Takakura H, Endo O, Yoshitsugu M, Watanabe N, Matsuzaki S: Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis. Cancer 2002; 94(6):1787-1795.
6. Shimada M, Hamatsu T, Yamashita Y, Rikimaru T, Taguchi K, Utsunomiya T, Shirabe K, Sugimachi K: Characteristics of multicentric hepatocellular carcinomas: comparison with intrahepatic metastasis. World J Surg 2001; 25(8):991-995.
7. Sonoyama T, Ochiai T, Hironaka T, Yamagishi H: Histopathologic differentiation of the main nodule determines outcome after hepatic resection for synchronous multicentric hepatocellular carcinomas. Hepatogastroenterology 2005; 52(63):862-865.
8. Yamamoto T, Kajino K, Kudo M, Sasaki Y, Arakawa Y, Hino O: Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology 1999; 29(5):1446-1452.
9. Sugimoto R, Okuda K, Tanaka M, Aoyagi S, Kojiro M: Metachronous multicentric occurrence of hepatocellular carcinoma after surgical treatment - clinicopathological comparison with recurrence due to metastasis. Oncol Rep 1999; 6(6):1303-1308.
10. Qin LX, Tang ZY: The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8(3):385-392.
11. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, Tsuneyoshi M: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108(3):768-775.
12. Shirabe K, Takenaka K, Taketomi A, Kawahara N, Yamamoto K, Shimada M, Sugimachi K: Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 1996; 77(6):1050-1055.
13. Ikeda Y, Shimada M, Hasegawa H, Gion T, Kajiyama K, Shirabe K, Yanaga K, Takenaka K, Sugimachi K: Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection. Hepatology 1998; 27(6):1567-1571.
14. Taketomi A, Shimada M, Shirabe K, Kajiyama K, Gion T, Sugimachi K: Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 1998; 83(1):58-63.
15. Shimada M, Rikimaru T, Sugimachi K, Hamatsu T, Yamashita Y, Aishima S, Taguchi K, Tanaka S, Shirabe K, Sugimachi K: The importance of hepatic resection for hepatocellular carcinoma originating from nonfibrotic liver. J Am Coll Surg 2000; 191:531-537.
16. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K: Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996; 131(1):71-76.
17. Shimada M, Takenaka K, Kawahara N, Kajiyama K, Yamamoto K, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K: Surgical treatment strategy for patients with stage IV hepatocellular carcinoma. Surgery 1996; 119(5):517-522.
18. Ikai I, Yamaoka Y, Yamamoto Y, Ozaki N, Sakai Y, Satoh S, Shinkura N, Yamamoto M: Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: proposal as a standard therapy. Ann Surg 1998; 227(3):433-439.
19. Taniai M, Tomimatsu M, Okuda H, Saito A, Obata H: Immuno-histochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma: relationship to histological grade. J Gastroenterol Hepatol 1993; 8(5):420-425.
20. Shimada M, Takenaka K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Sugimachi K: Des-gamma-carboxy prothrombin and alpha-fetoprotein positive status as a new prognostic indicator after hepatic resection for hepatocellular carcinoma. Cancer 1996; 78(10):2094-2100.
21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1(5):431-435.
22. Ikeda K, Saitoh S, Arase Y, Chayama K, Suzuki Y, Kobayashi M, Tsubota A, Nakamura I, Murashima N, Kumada H, Kawanishi M: Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 1999; 29(4):1124-1130.
23. Suou T, Mitsuda A, Koda M, Matsuda H, Maruyama S, Tanaka H, Kishimoto Y, Kohno M, Hirooka Y, Kawasaki H: Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study. Hepatol Res 2001; 20(3):301-311.
24. Ikeda K, Arase Y, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Chayama K, Murashima N, Kumada H: Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 2000; 32(2):228-232.
25. Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N: Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer 2001; 91(12):2378-2385.
26. Fukuda S, Okuda K, Imamura M, Imamura I, Eriguchi N, Aoyagi S: Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery 2002; 131(3):300-310.
27. Tanaka S, Shimada M, Shirabe K, Maehara S, Harimoto N, Tsujita E, Sugimachi K, Maehara Y: A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma. Hepatogastroenterology 2005; 52(63):862-865.
28. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334(11):693-699.